# SciMagix

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scimagix

- Industry: Pharmaceuticals
- Headquarters: Redwood City, US
- Website: www.scimagix.com
- Total disclosed funding: $25M
- Latest round: Series C (Jul 30, 2001)
- Investors on record: 6

## About

SciMagix, Inc is a dynamic company specializing in unique content and experiences across various sectors, including entertainment, lifestyle, and education, aimed at enhancing user engagement and satisfaction.Founded in 1998 and headquartered in Redwood City, US, SciMagix, Inc focuses on delivering innovative solutions to its clientele. The company has successfully raised a total of USD 25.00 mn through its latest funding round, Series C, which took place on July 30, 2001. Notable investors in this round included EuclidSR Partners and First Capital. SciMagix had previously engaged in two significant funding deals.SciMagix offers a diverse range of products and services designed to meet consumer demands within the marketplace. The company specializes in delivering unique content and experiences that engage users, primarily targeting the entertainment, lifestyle, and educational sectors. SciMagix serves urban centers throughout the UK and has expanded its reach to international markets, including Europe and North America, providing memorable user experiences.Revenue generation at SciMagix is structured around subscription models and direct service offerings for both businesses and consumers. Clients can engage in annual or monthly subscription plans for access to services and exclusive content. Their transactions are facilitated through an online platform, allowing users to select tailored packages tailored to their interests, supporting a steady revenue stream.In July 2001, SciMagix, Inc raised USD 25.00 mn in Series C funding, co-led by Dresdner Kleinwort Capital and EuclidSR Partners. The company plans to utilize this capital for upcoming product launches and expansions into new geographic regions. Specific markets targeted for expansion include additional urban centers in Europe and North America, with anticipated launches scheduled for the next fiscal year. This funding will bolster product development and enhance market penetration strategies.

## Funding rounds

- Series C, Jul 30, 2001, $25M — OMTI, EuclidSR Partners, Invesco, Tullis Health Investors, Mesa Verde Venture Partners, First Capital

## Investors

- OMTI — Series C
- EuclidSR Partners (https://capitalatlas.ai/funds/euclidsr-partners) — Series C
- Invesco (https://capitalatlas.ai/funds/invesco) — Series C
- Tullis Health Investors (https://capitalatlas.ai/funds/tullis-health-investors) — Series C
- Mesa Verde Venture Partners (https://capitalatlas.ai/funds/mesa-verde-venture-partners) — Series C
- First Capital (https://capitalatlas.ai/funds/first-capital) — Series C